Complete Filing Data
Zepp Health Corp reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $110.74 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Zepp Health Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$75.7M | -$31.0M | -$43.2M | $137.8M | $228.8M | $575.2M | $340.0M | $167.7M | $23.9M | -$37.9M |
| Cost of Revenue * | $112.4M | $1.84B | $3.34B | $4.94B | $5.10B | $4.34B | $2.71B | $238.9M | $1.28B | $785.9M |
| Revenue * | $182.6M | $352.9M | $613.6M | $6.25B | $6.43B | $5.81B | $3.65B | $2.05B | $1.56B | $896.5M |
| Selling And Marketing Expense | $46.5M | $44.5M | $68.3M | $438.3M | $358.7M | $182.0M | $96.5M | $44.0M | $27.8M | $19.2M |
| Research And Development Expense | $46.2M | $51.5M | $77.3M | $515.1M | $538.0M | $430.8M | $263.2M | $153.8M | $132.3M | $61.6M |
| Operating Income Loss | -$47.3M | -$30.5M | -$61.9M | $93.9M | $174.2M | $606.5M | $365.7M | $182.0M | $13.4M | -$40.1M |
| Operating Expenses | $117.5M | $122.8M | $180.7M | $1.21B | $1.16B | $861.3M | $573.7M | $312.7M | $262.8M | $150.7M |
| Net Income Loss Available To Common Stockholders Basic | -$75.7M | -$31.0M | -$43.2M | $137.8M | $228.8M | $572.7M | $113.5M | $46.1M | -$12.1M | -$61.3M |
| Income Tax Expense Benefit | $13.7M | -$2.4M | -$9.9M | $10.7M | $31.2M | $77.9M | $52.0M | $27.6M | $3.1M | -$897.0K |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$57.9M | -$34.6M | -$55.9M | $106.7M | $265.6M | $652.4M | $386.6M | $191.9M | $28.9M | -$38.8M |
| Income Loss From Continuing Operations After Income Taxes And Before Minority Interest And Income Loss From Equity Method Investments | -$71.6M | -$32.2M | -$46.0M | $95.9M | $234.5M | $574.5M | $334.6M | $164.3M | $25.8M | -$37.9M |
| Gross Profit | $70.2M | $92.4M | $118.9M | $1.31B | $1.33B | $1.47B | $939.5M | $494.7M | $276.2M | $110.6M |
| General And Administrative Expense | $24.9M | $26.8M | $35.1M | $258.3M | $261.8M | $248.5M | $214.0M | $114.9M | $102.6M | $70.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$102.0M | -$42.8M | -$65.3M | $121.6M | $163.2M | $587.3M | $411.4M | $173.4M | $29.5M | -$27.6M |
| Comprehensive Income Net Of Tax | -$101.9M | -$42.7M | -$65.1M | $122.5M | $162.3M | $589.1M | $415.1M | $174.0M | $29.5M | -$27.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$1.0M | $1.9M | $6.7M | $2.6M | -$21.3M | $2.7M | $14.7M | $9.5M | $303.0K | |
| Income Loss From Equity Method Investments | -$4.2M | $1.1M | $2.7M | $41.0M | -$4.7M | -$1.1M | $1.7M | $2.8M | -$1.8M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$25.1M | -$13.6M | -$28.6M | -$17.9M | -$45.1M | $11.3M | $60.4M | -$3.2M | $5.3M | $10.2M |
| Net Income Loss Attributable To Noncontrolling Interest | -$75.0K | -$66.0K | -$103.0K | -$851.0K | $953.0K | -$1.8M | -$3.7M | -$587.0K | ||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$75.0K | -$66.0K | -$103.0K | -$851.0K | $953.0K | -$1.8M | -$3.7M | -$587.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | -$181.0K | $318.0K | $1.1M | $0.00 | $4.0M | $620.0K | $2.3M | $1.6M | $0.00 | $0.00 |
| Income Taxes Paid | $499.0K | $74.4M | $82.4M | $91.7M | $52.1M | $35.9M | $9.6M | $3.6M | ||
| Deferred Income Tax Expense Benefit Including Other Adjustments | $13.4M | -$2.9M | -$9.9M | -$18.7M | -$10.4M | -$27.8M | -$32.9M | -$19.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $251.6M | $350.9M | $2.67B | $2.92B | $2.73B | $2.50B | $1.81B | $225.8M | $30.2M | -$21.0M | -$6.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $110.7M | $140.5M | $141.1M | $236.9M | $2.28B | $1.80B | $1.45B | $369.5M | $153.2M | $220.0M | $7.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$25.5M | $8.7M | -$81.0M | -$750.6M | $515.1M | $340.9M | $1.02B | $219.5M | -$72.1M | $202.4M | |
| Repayments Of Bank Debt | $12.6M | $103.8M | $108.1M | $953.4M | $643.1M | $20.0M | $30.0M | $10.0M | |||
| Gain Loss On Sale Of Property Plant Equipment | $56.0K | -$53.0K | $284.0K | $304.0K | -$7.4M | -$767.0K | -$26.0K | -$192.0K | |||
| Goodwill | $9.6M | $9.6M | $66.1M | $61.1M | $62.5M | $5.9M | $5.9M | $5.9M | $0.00 | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $91.1M | $133.7M | $128.6M | $1.47B | $2.27B | $1.80B | $1.44B | $366.3M | $153.2M | ||
| Taxes Payable Current | $508.0K | $986.0K | $2.7M | $2.6M | $27.7M | $67.9M | $54.0M | $21.6M | $20.6M | ||
| Short Term Investments | $997.0K | $5.2M | $34.3M | $19.4M | $18.4M | $17.2M | $50.5M | $13.7M | $9.2M | ||
| Retained Earnings Accumulated Deficit | $28.6M | $104.4M | $942.8M | $1.27B | $1.13B | $910.6M | $340.0M | $131.2M | -$36.5M | ||
| Property Plant And Equipment Net | $6.9M | $8.9M | $100.6M | $133.9M | $124.6M | $64.4M | $40.0M | $28.8M | $10.8M | ||
| Prepaid Expense And Other Assets Current | $17.4M | $16.9M | $108.3M | $315.0M | $152.9M | $67.4M | $58.2M | $51.1M | $8.7M | ||
| Long Term Investments | $225.9M | $238.5M | $1.69B | $1.55B | $444.0M | $406.1M | $208.9M | $85.2M | $78.1M | ||
| Liabilities Current | $195.4M | $155.1M | $1.67B | $2.15B | $2.79B | $2.48B | $1.39B | $877.2M | $634.4M | ||
| Liabilities And Stockholders Equity | $528.6M | $635.5M | $5.27B | $6.09B | $5.90B | $5.17B | $3.26B | $1.47B | $972.9M | ||
| Liabilities | $275.9M | $282.8M | $2.58B | $3.15B | $3.17B | $2.68B | $1.45B | $887.7M | $634.4M | ||
| Inventory Net | $56.8M | $84.9M | $1.02B | $1.25B | $1.22B | $893.8M | $484.6M | $249.7M | $192.4M | ||
| Intangible Assets Net Excluding Goodwill | $7.1M | $9.9M | $123.3M | $135.6M | $145.2M | $85.8M | $63.7M | $5.3M | $1.2M | ||
| Assets Current | $251.6M | $316.7M | $2.96B | $3.93B | $4.83B | $4.39B | $2.86B | $1.30B | $859.8M | ||
| Assets | $528.6M | $635.5M | $5.27B | $6.09B | $5.90B | $5.17B | $3.26B | $1.47B | $972.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$40.2M | -$14.0M | $105.8M | $29.3M | $44.6M | $111.1M | $97.1M | $22.1M | $15.8M | ||
| Accrued Liabilities And Other Liabilities | $37.6M | $44.5M | $197.8M | $316.1M | $252.3M | $352.2M | $214.0M | $93.8M | $47.6M | ||
| Accounts Receivable Net Current | $63.0M | $60.7M | $682.1M | $537.1M | $298.0M | $188.9M | $58.9M | $32.9M | $19.7M | ||
| Accounts Payable Current | $51.1M | $37.3M | $456.6M | $1.32B | $1.95B | $2.00B | $1.06B | $707.8M | $524.1M | ||
| Restricted Cash Current | $19.7M | $6.8M | $86.7M | $41.0M | $2.4M | $874.0K | $10.0M | $3.2M | |||
| Other Liabilities Noncurrent | $133.0K | $270.0K | $162.6M | $175.1M | $185.2M | $113.6M | $56.2M | $4.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $4.8M | $8.8M | $7.3M | $83.1M | $65.2M | $55.1M | $134.7M | $62.8M | $57.7M | $56.0M |
| Payments To Acquire Property Plant And Equipment | $1.4M | $1.6M | $1.2M | $46.1M | $83.6M | $34.3M | $17.1M | $21.5M | $10.3M | $2.9M |
| Payments To Acquire Longterm Investments | $7.0M | $282.0K | $1.9M | $1.07B | $82.2M | $180.9M | $109.9M | $23.6M | $62.9M | $2.0M |
| Net Cash Provided By Used In Operating Activities | -$24.4M | $42.6M | -$117.1M | -$232.4M | $157.3M | $428.0M | $707.6M | $238.3M | $17.3M | -$6.8M |
| Net Cash Provided By Used In Investing Activities | -$1.6M | $7.7M | -$6.2M | -$1.07B | -$206.9M | -$112.7M | -$324.8M | -$38.9M | -$99.4M | -$4.9M |
| Net Cash Provided By Used In Financing Activities | $477.0K | -$41.7M | $42.4M | $551.1M | $564.7M | $25.6M | $639.2M | $20.1M | $10.0M | $214.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.4M | $745.0K | -$33.9M | $158.8M | $80.0M | $32.4M | $5.7M | $33.0M | -$6.7M | $9.9M |
| Increase Decrease In Inventories | -$5.6M | -$51.9M | -$27.9M | $83.1M | $410.7M | $433.0M | $234.9M | $57.6M | $103.5M | $52.8M |
| Increase Decrease In Due From Related Parties Current | -$5.5M | -$7.4M | -$26.0M | -$544.6M | -$583.5M | $771.0M | $45.1M | $109.8M | $287.7M | $128.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$6.0M | $13.7M | -$9.7M | $7.8M | -$149.4M | $86.2M | $119.9M | $45.6M | $28.8M | $16.0M |
| Increase Decrease In Accrued Income Taxes Payable | -$478.0K | $592.0K | -$13.0K | -$25.1M | -$40.1M | $13.8M | $32.4M | $972.0K | $21.7M | -$1.1M |
| Increase Decrease In Accounts Receivable | $5.1M | -$36.4M | $22.9M | $239.9M | $131.2M | $130.0M | $26.1M | $13.2M | -$2.2M | $17.8M |
| Increase Decrease In Accounts Payable | $14.8M | -$27.8M | -$135.3M | -$673.2M | -$9.8M | $935.8M | $356.3M | $181.6M | $272.0M | $164.0M |
| Payments To Acquire Intangible Assets | $87.0K | $83.0K | $265.0K | $7.0M | $1.2M | $11.8M | $52.0M | $88.0K | $1.2M | |
| Increase Decrease In Other Noncurrent Liabilities | -$129.0K | -$23.3M | -$2.0M | -$10.1M | $68.7M | $57.3M | $51.3M | $4.9M | ||
| Increase Decrease In Contract With Customer Liability | -$36.0K | -$76.0K | -$355.0K | -$38.3M | -$2.2M | $38.9M | -$4.7M | $4.3M | $5.9M | |
| Proceeds From Short Term Debt | $11.0M | $56.5M | $124.7M | $1.47B | $1.21B | $20.0M | $30.0M | $10.0M | ||
| Increase Decrease In Other Noncurrent Assets | -$4.5M | $2.4M | $4.2M | -$8.6M | $33.0M | $2.7M | $3.2M | |||
| Increase Decrease In Notes Payable | -$8.6M | -$5.3M | $6.3M | $103.8M | -$2.2M | -$16.8M | $13.7M | $2.6M | ||
| Increase Decrease In Due To Related Parties | -$998.0K | -$2.5M | -$1.9M | $38.9M | -$3.6M | $4.1M | $5.8M | -$281.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-0.29 | $-0.13 | $-0.18 | $0.52 | $0.88 | $2.24 | $0.51 | $0.65 | $-0.22 | $-1.22 |
| Earnings Per Share Basic | $-0.29 | $-0.13 | $-0.18 | $0.55 | $0.92 | $2.35 | $0.54 | $0.68 | $-0.22 | $-1.22 |
| Weighted Average Number Of Shares Outstanding Basic | 258.9M | 243.1M | 246.3M | 252.2M | 248.5M | 243.6M | 211.9M | 67.8M | 55.6M | 50.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 258.9M | 243.1M | 246.3M | 264.4M | 260.4M | 256.0M | 225.0M | 76.3M | 55.6M | 50.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other Income | -$656.0K | -$525.0K | $6.5M | $27.4M | -$929.0K | $13.2M | $8.8M | $4.6M | $14.7M | $1.1M |
| Interest Paid Net | $89.0K | $6.3M | $8.3M | $47.1M | $14.9M | $286.0K | $1.3M | $2.0M | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.8M | $8.8M | $7.4M | $84.0M | $67.2M | $55.1M | $134.7M | $62.8M | $57.7M | $45.6M |
| Realized Investment Gains Losses | $109.0K | $84.0K | $13.5M | $1.8M | $261.0K | $2.4M | ||||
| Additional Paid In Capital | $278.1M | $273.4M | $1.69B | $1.64B | $1.55B | $1.48B | $1.37B | $72.4M | $50.8M |
Most recent annual filing with the SEC: April 25, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.